Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery
NCT07859189Phase 4Not yet recruiting
- Sponsor
- General Authority for Teaching Hospitals and Institutes
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in class III obesity, sponsored by General Authority for Teaching Hospitals and Institutes. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
class III obesity
Beyond the preview
Go deeper on NCT07859189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07859189.